SCHEMBL15525962

SCHEMBL15525962

NOC(=O)c1cnc(Cl)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 2/20 0.40
▸ CYP2C9 P11712 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ NLRP3 Q96P20 1/20 0.36
▸ SIRT6 Q8N6T7 1/20 0.36
▸ NAPRT Q6XQN6 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ RAB9A P51151 5/20 0.31
▸ NPC1 O15118 4/20 0.31
▸ PKM P14618 1/20 0.31
▸ HAVCR2 Q8TDQ0 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ MKNK1 Q9BUB5 1/20 0.30
▸ MKNK2 Q9HBH9 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ CASP3 P42574 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474122 0.81 KDM4E (0.44) NNMTMAPTRAB9ANPC1ALDH1A1
SCHEMBL29551416 0.81 KDM4E (0.44) NNMTMAPTRAB9ANPC1ALDH1A1
SCHEMBL384113 0.79 NNMT (0.61) NNMTSIRT6MKNK1MKNK2KMT2A
SCHEMBL29799541 0.79 NNMT (0.61) NNMTSIRT6MKNK1MKNK2KMT2A
SCHEMBL16333365 0.78 NNMT (0.42) NNMTSIRT6NAPRTMAPTHAVCR2
SCHEMBL28662886 0.78 NNMT (0.42) NNMTCYP2C9SIRT6NAPRTMAPT
SCHEMBL29577063 0.78 NNMT (0.42) NNMTSIRT6NAPRTMAPTHAVCR2
SCHEMBL18298896 0.77 ATR (0.43) NNMTCYP2C9KCNH2NLRP3NFKB1
SCHEMBL22834911 0.77 CA12 (0.42) NNMTCYP2C9MAPTRAB9ANPC1
SCHEMBL31280472 0.77 NNMT (0.41) NNMTCYP2C9KCNH2NLRP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013186612-A1 THE USE OF SUBSTITUTED 2-PHENYL-3H-QUINAZOLIN-4-ONES AND ANALOGS FOR INHIBITING BET (BROMODOMAIN AND EXTRA TERMINAL DOMAIN) PROTEINS RVX THERAPEUTICS INC. (CA) 2013-12-19 — — WO disclosed
WO-2013156869-A1 TREATMENT OF DISEASES BY EPIGENETIC REGULATION RVX THERAPEUTICS INC. (CA) 2013-10-24 — — WO disclosed
Send feedback